Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 2, 2020

CDC’s Covid-19 diagnostic panel to use Promega’s amplification reagent

The Centers for Disease Control and Prevention (CDC) has added Promega’s amplification reagent GoTaq Probe 1-Step RT-qPCR System to its coronavirus (Covid-19) diagnostic protocol for emergency use.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.


The Centers for Disease Control and Prevention (CDC) has added Promega’s amplification reagent GoTaq Probe 1-Step RT-qPCR System to its coronavirus (Covid-19) diagnostic protocol for emergency use.

Promega’s system is a ready-to-use master mix of optimised components for RT-qPCR using hydrolysis probes.

It is designed for sensitive detection and quantification of a broad range of DNA or RNA targets in the presence of a wide range of PCR inhibitors.

The US Food and Drug Administration (FDA) recently approved an amendment to the CDC’s diagnostic Covid-19 assay that includes an acknowledgement that GoTaq is an approved amplification reagent for laboratories that use the CDC’s assay.

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

CDC’s assay protocol is used by several public health labs and clinical testing labs across the US and is referenced by labs globally.

Promega Clinical Diagnostics director Heather Tomlinson said: “Thanks to the CDC acting quickly to make product additions to their protocol, labs now have one more CDC-approved master mix when performing the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel.

“The Promega GoTaq Probe 1-Step RT-qPCR System expands the testing capacity in the US by being another option for labs to use for the amplification process in the CDC’s testing protocol.”

The company supplies automation, sample extraction and diagnostic reagents across the world. Promega accelerated the production in January to address unprecedented demand for Covid-19-related tools.

Currently, Promega reagents are incorporated in 15 Covid-19 diagnostic tests developed by different global diagnostic manufacturers.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU